Combined LF scores, such as the Child–Pugh score [16, 38], the model for end-stage liver disease score [39], and the albumin–bilirubin score [40–42], demonstrated usefulness in assessing the risk of RILD within 3–4 months after radiotherapy in either conventional or ablative radiotherapy. Here, ALB is linked to End Stage Liver Disease.